Immune Monitoring Package

The Serametrix Immune Monitoring Package measures different elements of the immune system, delivering a comprehensive data set on humoral and cellular anti-tumor immunity in cancer patients. The package allows pharmaceutical companies to conduct immune monitoring studies on patients and identify those patients most likely to benefit from treatment. More...

Clinical Trial Support

All immunotherapy monitoring studies conducted at Serametrix in support of clinical trials are carried out to GLP standards. Our commitment to quality is evident in every assay and every project. From training, security, tracking, and redundancy your samples and data are safe with us. We’ve incorporated the following features to ensure quality of data: More...

Why Serametrix?

Serametrix provides solutions to the problem of monitoring immune response to immunotherapies in clinical trial cancer patients. In partnership with the Ludwig Institute for Cancer Research (LICR) and other leading institutes Serametrix has developed a suite of immunoassays that monitor anti-tumor immunity in patients enrolled into clinical trials for novel cancer therapies. Serametrix is part owned by the LICR. More...

 

©2013 Serametrix  l  US: +1-760-652-4060  l  Europe: +44 (0)20 8123 8612 | info@serametrix.com